Table 4. Comparison of anti-HCV assays using commercial seroconversion panels.
| Seroconversion panel | Positive bleeds/Serial bleeds tested (N) | ||
|---|---|---|---|
| Elecsys anti-HCV II | ARCHITECT anti-HCV | AFIAS anti-HCV | |
| HCV6226 (01–12) | 4/12 | 4/12 | 4/12 |
| HCV6228 (01–12) | 4/12 | 4/12 | 4/12 |
| HCV9041 (01–08) | 4/8 | 4/8 | 4/8 |
| HCV9044 (01–06) | 3/6 | 3/6 | 3/6 |
| HCV9046 (01–05) | 4/5 | 4/5 | 4/5 |
| HCV9047 (01–10) | 4/10 | 4/10 | 4/10 |
| HCV10071 (01–07) | 5/7 | 5/7 | 5/7 |
| HCV10165 (01–09) | 4/9 | 4/9 | 4/9 |
| HCV10185 (01–05) | 4/5 | 4/5 | 4/5 |
| HCV10235 (01–05) | 3/5 | 3/5 | 3/5 |
| Total | 39/79 (49.4%) | 39/79 (49.4%) | 39/79 (49.4%) |
Abbreviations: AFIAS, Automated Fluorescent Immunoassay System; anti-HCV, antibody to hepatitis C virus.